1.

Record Nr.

UNINA9910458880703321

Titolo

Redefining adaptation studies [[electronic resource] /] / edited by Dennis Cutchins, Laurence Raw, James M. Welsh

Pubbl/distr/stampa

Lanham, : Scarecrow Press, Inc., 2010

ISBN

1-282-52185-3

9786612521850

0-8108-7299-4

Descrizione fisica

1 online resource (197 p.)

Altri autori (Persone)

CutchinsDennis R <1963-> (Dennis Ray)

RawLaurence

WelshJames Michael

Disciplina

791.4301

808.2/3071

808.23071

Soggetti

Film adaptations - Authorship

Motion picture authorship - Study and teaching

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Includes filmography.

Nota di contenuto

Contents; Foreword; Introduction:How Should We Teach It? How Could We Teach It?; Chapter 01. Adapting Wilde for the Performance Classroom: "No Small Parts"; Chapter 02. "It Must All Change Now": Victor Hugo's Lucretia Borgia and Adaptation; Chapter 03. "Never Seek to Tell Thy Love": E-Adapting Blake in the Classroom; Chapter 04. Adaptation and Creative Writing: Brokeback Mountain on the London Underground; Chapter 05. Pedagogy and Policy in Intermedial Adaptations; Chapter 06. Toward a Pedagogy for Adaptation Studies

Chapter 07. Writing the Adaptation: Teaching an Upper-Division College Course for the ScreenwriterChapter 08. Whose Life IS It, Anyway?: Adaptation, Collective Memory, and (Auto)Biographical Processes; Chapter 09. The Numbers Game: Quantifying the Audience; Chapter 10. Engaging the Ear: Teaching Radio Drama Adaptations; Chapter 11. The Pleasures of "Theater Film": Stage to Film Adaptation;



Filmography; Bibliography; Index; About the Editors and Contributors

Sommario/riassunto

Transcending the literature/film paradigm of typical film adaptation courses, these essays focus on the idea of 'adaptation' and what it means in different socio-political contexts. This volume not only suggests how 'adaptation' might be used in different disciplines but how it might improve the learning experience for teachers and students alike.

2.

Record Nr.

UNINA9910140505703321

Titolo

Method validation in pharmaceutical analysis : a guide to best practice. / / edited by Joachim Ermer and Phil Nethercote

Pubbl/distr/stampa

Weinheim, Germany : , : Wiley-VCH Verlag, , 2015

©2015

ISBN

1-5231-4402-5

3-527-67218-4

3-527-67220-6

3-527-67219-2

Edizione

[2nd ed.]

Descrizione fisica

1 online resource (437 p.)

Disciplina

615.1901

Soggetti

Drugs - Analysis

Methodology - Validity

Pharmacology

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Method Validation in Pharmaceutical Analysis; Contents; Foreword; List of Contributors; Chapter 1 Analytical Validation within the Pharmaceutical Lifecycle; 1.1 Development of Process and Analytical Validation Concepts; 1.2 Alignment between Process and Analytics: Three-Stage Approach; 1.3 Predefined Objectives: Analytical Target Profile; 1.4 Analytical Life Cycle; References; Chapter 2 Analytical Instrument Qualification; 2.1 Analytical Instrument and System Qualification; 2.1.1 Data Quality and Integrity in a GMP Environment;



2.1.1.1 Criteria for Quality Data

2.1.1.2 Regulatory Rationale for Qualified Analytical Instruments2.1.2 USP General Chapter ; 2.1.2.1 Data Quality Triangle; 2.1.2.2 Analytical Instrument Qualification Life Cycle: the Four Qs Model; 2.1.2.3 Risk-Based Classification of Apparatus, Instruments, and Systems; 2.1.2.4 Roles and Responsibilities for AIQ; 2.1.2.5 Software Validation for Group B and C Systems; 2.1.3 Enhancement of  and Harmonization of a Risk-Based Approach to Instruments and Systems with GAMP Laboratory GPG Second Edition; 2.1.3.1 Increased Granularity of USP  Groups

2.1.3.2 Clarification of AIQ Terminology2.1.3.3 A Continuum of Analytical Apparatus, Instruments, and Systems; 2.1.3.4 Mapping USP  Instrument Groups to GAMP Software Categories; 2.1.3.5 Enhanced Data Quality Triangle; 2.1.4 Risk-Based Approaches to Analytical Instrument and System Qualification; 2.1.4.1 Expanded  Instrument and System Categories; 2.2 Efficient and Economic HPLC Performance Qualification; 2.2.1 Introduction; 2.2.1.1 The Importance of Analytical Instrument Qualification; 2.2.1.2 Terms and Definitions; 2.2.1.3 Continuous Performance Qualification: More by Less

2.2.2 Development of the Revised OQ/PQ Parameters List2.2.3 Transfer of Modular Parameters into the Holistic Approach; 2.2.3.1 Autosampler; 2.2.3.2 Solvent Delivery System; 2.2.3.3 Detector; 2.2.4 OQ/PQ Data in Comparison with SST Data; 2.2.5 Control Charts; 2.2.6 General Procedure for Continuous PQ; 2.2.7 Concluding Remarks; Acknowledgment; Abbreviations; References; Chapter 3 Establishment of Measurement Requirements - Analytical Target Profile and Decision Rules; 3.1 Introduction; 3.2 Defining the Fitness for Intended Use; 3.3 Decision Rules

3.4 Overview of Process to Develop Requirements for Procedure Performance3.5 Decision Rules and Compliance; 3.6 Calculating Target Measurement Uncertainty; 3.6.1 Coverage Factor, k, and Data Distributions; 3.7 Types of Decision Rules; 3.7.1 Decision Rules That Use Guard Bands; 3.8 Target Measurement Uncertainty in the Analytical Target Profile; 3.8.1 Cost of Analysis; 3.9 Bias and Uncertainty in a Procedure; 3.10 ATP and Key Performance Indicators; 3.11 Measurement Uncertainty; 3.11.1 What Uncertainty Is; 3.11.2 Reporting Measurement Uncertainty; 3.11.3 How Uncertainty is Estimated

3.11.4 Uncertainty Contains All Sources of  Random Variability

Sommario/riassunto

This second edition of a global best-seller has been completely redesigned and extensively rewritten to take into account the new Quality by Design (QbD) concept in pharmaceutical manufacturing. As in the first edition, the analytical requirements during the entire product lifecycle are covered, but now a new section is included on continued performance monitoring and the transfer of analytical procedures. Two case studies from the pharmaceutical industry illustrate the concepts and guidelines presented, and the standards and regulations from the US (FDA), European (EMA) and global (ICH) regul